Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism

Authors

Institutions

Publication Details

Journal
Med
Published
2025-03-18
DOI
https://doi.org/10.1016/j.medj.2025.100611
Citations
2
Primary Topic
Hyperglycemia and glycemic control in critically ill and hospitalized patients
Type
article
Field-Weighted Citation Impact
2.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism

Antonia Dastamani, Paul Thornton, Sonya Galcheva, Erin O’Boyle et al.
2 citations
Med
Hyperglycemia and glycemic control in critically ill and hospitalized patients
2.59
article

Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism

Antonia Dastamani, Paul Thornton, Sonya Galcheva, Erin O’Boyle, Mehmet Nuri Özbek, Violeta Iotova, Maria Melikyan, Diva D. De León, Kineret Mazor‐Aronovitch, Hüseyin Demirbilek, Susann Empting, Klaus L. Mohnike, Nino Kheladze, Henrik Thybo Christesen, Davelyn Hood, María Clemente, Brian K. Roberts
article en
2 citations

Abstract

No abstract available for this paper.
MedVol. 6(6)
Children's Hospital of Philadelphia (US), Medical University of Varna (BG), Great Ormond Street Hospital (GB), Odense University Hospital (DK), Cook Children's Medical Center (US), Monash Children’s Hospital (AU), Revolution Medicines (United States) (US), Vall d'Hebron Hospital Universitari (ES), Sağlık Bilimleri Üniversitesi (TR), Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR), Edmond and Lily Safra Children's Hospital (IL), Nuclear Research Institute Rez (Czechia) (CZ), University College London (GB), Yerevan State Medical University (AM), Hacettepe University (TR), Otto-von-Guericke-Universität Magdeburg (DE)
Zero hunger
Openalex Percentile: Top 11%
Hyperglycemia and glycemic control in critically ill and hospitalized patients
2.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism — Antonia Dastamani, Paul Thornton, et al. · Med (2025) | TGRS Research Map | TGRS